|
|
Volumn 15, Issue 5, 2000, Pages 986-989
|
|
Tolerability of paroxetine in Parkinson's disease: A prospective study
|
|
Author keywords
Depression; Parkinson's disease; Paroxetine; Safety; SSRI; Tolerability
|
|
Indexed keywords
AMANTADINE;
ANTIPARKINSON AGENT;
BENSERAZIDE;
BROMOCRIPTINE;
CARBIDOPA;
DOPAMINE RECEPTOR STIMULATING AGENT;
LEVODOPA;
METIXENE;
PAROXETINE;
PERGOLIDE;
ROPINIROLE;
SELEGILINE;
SEROTONIN UPTAKE INHIBITOR;
TOLCAPONE;
TRICYCLIC ANTIDEPRESSANT AGENT;
TRIHEXYPHENIDYL;
ADULT;
ADVERSE DRUG REACTION;
AGED;
AGITATION;
ANXIETY;
ARTICLE;
CLINICAL TRIAL;
CONFUSION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEPRESSION;
DIARRHEA;
DISEASE EXACERBATION;
DRUG EFFICACY;
DRUG HYPERSENSITIVITY;
DRUG SAFETY;
DRUG TOLERABILITY;
FEMALE;
HAMILTON SCALE;
HEADACHE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
NAUSEA;
OUTPATIENT;
PARKINSON DISEASE;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
RISK FACTOR;
SIDE EFFECT;
TREMOR;
AGED;
ANTIPARKINSON AGENTS;
CLINICAL PROTOCOLS;
DEPRESSION;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG THERAPY, COMBINATION;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
PARKINSON DISEASE;
PAROXETINE;
PROSPECTIVE STUDIES;
SEROTONIN UPTAKE INHIBITORS;
TREATMENT OUTCOME;
|
|
EID: 0033809642
PISSN: 08853185
EISSN: None
Source Type: Journal
DOI: 10.1002/1531-8257(200009)15:5<986::AID-MDS1034>3.0.CO;2-I Document Type: Article |
|
Times cited : (113)
|
|
References (12)
|
